CANY
OFIX icon

Caxton Associates (New York)’s Orthofix Medical OFIX Stock Holding History

Caxton Associates (New York)’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-35,655
Closed -$597K – 610
2023
Q1 		$597K Buy
35,655
+19,785
+125% +$387K 0.09% 228
2022
Q4 		$326K Buy
+15,870
New +$280K 0.02% 312

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Associates (New York)'s OFIX Position: Q2 2023 in Review

Caxton Associates (New York) sold out of Orthofix Medical (OFIX) in Q2 2023, closing a stake of 35,655 shares — an estimated $597K sold.

Caxton Associates (New York) first reported a position in OFIX in Q4 2022 and held it in 2 quarters. The position peaked at $597K in Q1 2023. 149 funds tracked by Wall St. Rank hold OFIX as of Q2 2023.

  • Caxton Associates (New York) reported no remaining Orthofix Medical position as of Q2 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 35,655 Orthofix Medical shares in Q2 2023, an estimated $597K.
  • Caxton Associates (New York) first reported a position in Orthofix Medical in Q4 2022 and held it in 2 quarters.
  • Caxton Associates (New York)'s Orthofix Medical position peaked at $597K in Q1 2023.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2023.

Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.